Trans-(4-methylaminocyclohexyl)carbamic acid tert-butyl ester is a key chiral intermediate in organic synthesis, characterized by a trans-substituted cyclohexyl ring bearing both a methylamino group and a tert-butoxycarbonyl (Boc)-protected amino group. This specific stereochemistry is crucial for its application. Its primary and well-documented application is in the pharmaceutical industry as a critical building block for the synthesis of active pharmaceutical ingredients (APIs). It serves as a core structural motif for several drug candidates and approved drugs, most notably as a key intermediate in the synthesis of certain kinase inhibitors. The Boc-protected amine and the secondary amine functionalities make it a versatile precursor for further derivatization and coupling reactions in medicinal chemistry campaigns. This compound is a high-value synthetic intermediate, and its availability supports research and development in targeted therapies, particularly in oncology. Handling requires standard precautions for amine-containing compounds.